Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors (vol 14, pg 50, 2008)

被引：0
|
作者：
Kurth, M. A. H.
DiMichele, D.
Sexauer, C.
Sanders, J. M.
Torres, M.
Zappa, S. C.
Ragni, M.
Leonard, N.
机构：
来源：
HAEMOPHILIA | 2008年 / 14卷 / 04期
关键词：
D O I：
10.1111/j.1365-2516.2008.01809.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：878 / 878
页数：1
相关论文
共 50 条
  • [1] Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia - A patients with high titre factor VIII inhibitors (vol 14, pg 50, 2008)
    Kurth, M. A. H.
    DiMichele, D.
    Sexauer, C.
    Sanders, J. M.
    Torres, M.
    Zappa, S. C.
    Ragni, M.
    Leonard, N.
    HAEMOPHILIA, 2008, 14 (02) : 414 - 414
  • [2] Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors
    Kurth, M. A. H.
    Dimichele, D.
    Sexauer, C.
    Sanders, J. M.
    Torres, M.
    Zappa, S. C.
    Ragni, M.
    Leonard, N.
    HAEMOPHILIA, 2008, 14 (01) : 50 - 55
  • [3] Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A
    Bidlingmaier, C.
    Kurnik, K.
    Escuriola-Ettingshausen, C.
    Jager, R.
    Klamroth, R.
    Male, C.
    Marosi, A.
    Nemes, L.
    Von Stackelberg, A.
    Kreuz, W.
    HAEMOPHILIA, 2011, 17 (05) : E837 - E840
  • [4] The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile
    Greninger, D. A.
    Saint-Remy, J. M.
    Jacquemin, M.
    Benhida, A.
    Dimichele, D. M.
    HAEMOPHILIA, 2008, 14 (02) : 295 - 302
  • [5] IMMUNE TOLERANCE INDUCTION (ITI) WITH A SINGLE FACTOR VIII/VON WILLEBRAND FACTOR CONCENTRATE IN HAEMOPHILIA A PATIENTS WITH INHIBITORS - DATA FROM THE OBSITI STUDY
    Escuriola-Ettingshausen, C.
    HAEMOPHILIA, 2020, 26 : 62 - 63
  • [6] Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE®), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: A multicentre, retrospective study
    Robertson, Jeremy D.
    Higgins, Pauline
    Price, Jamie
    Dunkley, Scott
    Barrese, Giulio
    Curtin, Julie
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1046 - 1051
  • [7] Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response
    Gringeri, A.
    Musso, R.
    Mazzucconi, M. G.
    Piseddu, G.
    Schiavoni, M.
    Pignoloni, P.
    Mannucci, P. M.
    HAEMOPHILIA, 2007, 13 (04) : 373 - 379
  • [8] Treatment of Haemophilia a (HA) Patients with Inhibitors: Immune Tolerance Induction with a Single Factor VIII/Von Willebrand Factor Concentrate in an Observational Immune Tolerance Induction Study (ObsITI)
    Ettingshausen, C. Escuriola
    Berntorp, Erik
    Dargaud, Yesim
    Gutowski, Zeynep
    Negrier, Claude
    Pavlova, Anna
    Oldenburg, Johannes
    BLOOD, 2018, 132
  • [9] Immune tolerance with a high purity plasma derived factor VIII containing von Willebrand factor in haemophilia A patients with high responding inhibitors.
    Polack, B
    Beurrier, P
    Rothschild, C
    Orsini, F
    Faradji, A
    Liennhard, A
    Fressinaud, E
    Goudemand, J
    BLOOD, 2004, 104 (11) : 846A - 846A
  • [10] Immune tolerance induction in haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study (ObsITI)
    Ettingshausen, Carmen Escuriola
    Berntorp, Erik
    Dargaud, Yesim
    Gutowski, Zeynep
    Lacroix-Desmazes, Sebastien
    Negrier, Claude
    Pavlova, Anna
    Schved, Jean-Francois
    Lavigne-Lissalde, Geraldine
    Oldenburg, Johannes
    HAEMOPHILIA, 2016, 22 : 124 - 124
12345